Didactics-Quality Indicators and Training for Cytoreductive Surgery

Quality Indicators and Training for Cytoreductive Surgery

Video Transcription

Video Summary

In this video, the speaker discusses the importance of quality indicators and training for cytoreductive surgery in the treatment of ovarian cancer. The speaker highlights the increasing prevalence of ovarian cancer, particularly in low-middle income countries, and emphasizes the need for a dedicated and well-trained surgical team. They discuss the shift from palliation to cure in the treatment of ovarian cancer, aided by advancements in biology, PARP inhibitors, and surgery. The speaker also emphasizes the importance of achieving optimal quality surgery, as it can lead to improved outcomes and reduced costs. They discuss the decision-making process for primary debulking surgery versus neoadjuvant chemotherapy, as well as the need for a multidisciplinary team approach and thorough intraoperative assessment. The speaker also touches on quality improvement programs, research, and clinical trials in the field of ovarian cancer surgery. The video concludes with a discussion on resource management and the importance of referring patients to specialized services for early intervention.

Asset Subtitle

Asima Mukhopadhyay
March 2022

Keywords

cytoreductive surgery

ovarian cancer

quality indicators

training

surgical team

PARP inhibitors